ArticleMolecular biomedicine2025

Distinct survival, optimal combination strategy of immunotherapy, and immunophenotype in uncommon and 20ins EGFR-mut lung adenocarcinoma: a multi-center study.

Yiting Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.